FealtySign in
Promise-keeping streak4 kept in a rowguidance & buyback

STERIS plc

(STE)

CIK 1757898 · SEC filings only

Not gradedDividend record
shown as history
company entity
25 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

25 declarations · 8 raised · 16 held · 0 cut · held 24 quarters

  1. HELD$0.6300/shperiod ended 2026-06-30Filing ↗
  2. HELD$0.6300/shperiod ended 2025-12-31Filing ↗
  3. RAISED$0.6300/shperiod ended 2025-09-30Filing ↗
  4. HELD$0.5700/shperiod ended 2025-06-30Filing ↗
  5. HELD$0.5700/shperiod ended 2024-12-31Filing ↗
  6. RAISED$0.5700/shperiod ended 2024-09-30Filing ↗
  7. HELD$0.5200/shperiod ended 2024-06-30Filing ↗
  8. HELD$0.5200/shperiod ended 2023-12-31Filing ↗
  9. RAISED$0.5200/shperiod ended 2023-09-30Filing ↗
  10. HELD$0.4700/shperiod ended 2023-06-30Filing ↗
  11. HELD$0.4700/shperiod ended 2022-12-31Filing ↗
  12. RAISED$0.4700/shperiod ended 2022-09-30Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
Not yet gradedBuyback record
harness minimum not met
company entity
0 resolved promises

Not enough resolved promises to grade

0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Pro

buyback history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Open promises (1)

Open · buyback authorization

STERIS's Board of Directors has authorized a new share buyback program for the purchase of up to $1 billion of the Company's ordinary shares

resolves in ~562 days$1.00Breceipt (opens in a new tab)
0 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
A+Guidance record
grade
company entity
4 resolved promises

Sector median (Industrial Applications and Services): B+ across 28 graded companies

Resolved promises

Pro

Full say-do history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance by basis

7 of 11 guidance figures that were graded or dropped for basis could not be graded on the same basis (64%). Guidance marked “not judged” is in neither number.

Guidance typeSaidGradedDroppedOther
Revenue · non-GAAPcannot be graded5023
Revenue · basis not stated184014
EPS · non-GAAPcannot be graded160511

Said counts every revenue and EPS guidance figure on record. Dropped counts figures whose period was reported but which have no comparable GAAP actual in SEC XBRL. Other covers open, superseded, withdrawn and otherwise unresolved figures. The coverage note below counts every figure shown but not graded, including figures whose period has not been reported, so it can be larger.

How the site-wide rate is measured

Compare across companies

Guidance shown, not graded (24)

We show what was said — with its source filing — but never score it. The line under each statement says why.

  1. eps guidance fy · Aug 5, 2026
    Adjusted earnings per diluted share are anticipated to be in the range of $11.10 to $11.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. revenue guidance fy · Aug 5, 2026
    constant currency organic revenue growth of 6-7%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. eps guidance fy · May 11, 2026
    Adjusted earnings per diluted share is anticipated to be in the range of $11.10 to $11.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Feb 4, 2026
    Adjusted earnings per diluted share from continuing operations are expected to be in the range of $10.15 to $10.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Nov 5, 2025
    Adjusted earnings per diluted share from continuing operations are also increasing and are now expected to be in the range of $10.15 to $10.30
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Aug 6, 2025
    Adjusted earnings per diluted share from continuing operations is also unchanged in the range of $9.90 to $10.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · May 14, 2025
    Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of $9.90 to $10.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. eps guidance fy · Feb 5, 2025
    Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of $9.05 to $9.15
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. eps guidance fy · Aug 6, 2024
    Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of $9.05 to $9.25
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. revenue guidance fy · Aug 6, 2024
    Constant currency organic revenue from continuing operations is anticipated to increase 6-7%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. eps guidance fy · Nov 7, 2023
    Adjusted earnings per diluted share are anticipated to be in the range of $8.60 to $8.80
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. revenue guidance fy · Nov 7, 2023
    constant currency organic revenue growth of 6-7%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  13. revenue guidance fy · Feb 8, 2023
    Constant currency organic revenue is now anticipated to grow approximately 7%
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗
  14. eps guidance fy · Feb 8, 2023
    adjusted earnings per diluted share are now anticipated to be in the range of $8.00 to $8.10
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Nov 9, 2022
    The adjusted earnings per diluted share range of $8.40 to $8.60 remains unchanged
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. eps guidance fy · May 12, 2022
    Adjusted earnings per diluted share are anticipated to be in the range of $8.55 to $8.75
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. revenue guidance fy · Feb 8, 2022
    Constant currency organic revenue growth is now anticipated to be approximately 11%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · Feb 8, 2022
    Adjusted earnings per diluted share are now anticipated to be in the range of $7.85 to $7.95
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. revenue guidance fy · Nov 2, 2021
    constant currency organic revenue growth in the range of 10-11%
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · Nov 2, 2021
    adjusted earnings per share of $7.60 to $7.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. revenue guidance fy · Aug 9, 2021
    Constant currency organic revenue growth is now expected to be in the range of 10-11% for fiscal 2022
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance fy · Aug 9, 2021
    Adjusted earnings per diluted share are anticipated to be in the range of $7.60 - $7.85
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. eps guidance fy · May 18, 2021
    Adjusted earnings per diluted share are anticipated to be in the range of $7.40 - $7.65
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. revenue guidance fy · May 18, 2021
    Constant currency organic revenue growth is expected to be in the range of 8-9% for fiscal 2022.
    Not judged — the company guided on a basis or for a measure that the reported figure we hold does not match.Filing ↗

Open promises (2) · 8 superseded

Open · revenue guidance fy

We are well positioned to finish another record year in revenue and income during fiscal 2021

unresolved — no outcome on filereceipt (opens in a new tab)
Open · revenue guidance fy

as reported revenue growth of 7-8%

resolves in ~521 daysreceipt (opens in a new tab)
Superseded · revenue guidance fy

For fiscal 2027, the Company expects as reported revenue to increase 7-8%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

For fiscal 2026, the Company expects as reported revenue from continuing operations to increase 8-9%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

As reported revenue is expected to increase approximately 12%

revised by a later guidance$12.0000receipt (opens in a new tab)
Superseded · revenue guidance fy

the Company now expects as reported revenue from continuing operations to increase 8-9%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

STERIS expects as reported revenue of approximately $4.5 billion.

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

For fiscal 2026, the Company expects as reported revenue from continuing operations to increase 6-7%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

For fiscal 2025, the Company continues to expect as reported revenue from continuing operations to increase 6.5-7.5%

revised by a later guidancereceipt (opens in a new tab)
Superseded · revenue guidance fy

as reported revenue is now anticipated to grow 8%

revised by a later guidancereceipt (opens in a new tab)

Credibility timeline

IN LINE · May 31, 2022ABOVE · May 26, 2023UNRESOLVABLE · Nov 7, 2023IN LINE · May 29, 2025IN LINE · May 29, 2026
20222026
Timeline as a list
  • May 31, 2022IN LINESTERIS now expects as reported revenue of approximately $4.6 billion
  • May 26, 2023ABOVEAs reported revenue is now anticipated to grow 6%
  • Nov 7, 2023UNRESOLVABLErevenue growth of 9-10%
  • May 29, 2025IN LINEFor fiscal 2025, the Company now expects as reported revenue to increase approximately 6%
  • May 29, 2026IN LINEthe Company expects as reported revenue from continuing operations to increase 8-9%
4 resolved guidance promises · 25 not graded (no comparable reported figure) · resolver resolver-v5 · score score-v1. Every verdict links to its source filing. Full methodology →